Project by iMed Technologies' Representative Director Kenichi Kono selected by NEDO

iMed Technologies, Inc. (headquartered in Shibuya-ku, Tokyo; Representative Director and CEO, physician Kenichi Kono; Representative Director and COO, Motohisa Kaneko; hereafter iMed Technologies) is developing surgical support AI for ischemic stroke and subarachnoid hemorrhage. Under the fiscal 2019 “R&D-type Venture Support Program / NEDO Entrepreneurs Program (NEP),” Representative Director and CEO Kenichi Kono has been selected for the research and development theme “Development of surgical support AI to improve the safety of ischemic stroke and subarachnoid hemorrhage surgery.”

*For details, see the website of the New Energy and Industrial Technology Development Organization (NEDO). https://www.nedo.go.jp/koubo/CA3_100202.html

*List of grant recipients https://www.nedo.go.jp/content/100897994.pdf

Under the mission of “Delivering safe surgery to the world,” iMed Technologies is developing surgical support AI for endovascular surgery. Endovascular surgery for ischemic stroke and subarachnoid hemorrhage is minimally invasive and places little burden on the body, and the number of such procedures is increasing at more than 10% per year. Because multiple small medical devices such as catheters must be checked under X-ray fluoroscopy, surgeons and assistants currently cross-check each other during the procedure, and oversights can occur. iMed Technologies aims to support this labor-intensive work with surgical AI and deliver safe surgery to the world.

With this selection under the NEDO Entrepreneurs Program, iMed Technologies will further accelerate the commercialization of its surgical support AI for ischemic stroke and subarachnoid hemorrhage.

■iMed Technologies, Inc. Company Profile Company name: iMed Technologies, Inc. Address: 5F Eclat Shibuya, 3-6-2 Shibuya, Shibuya-ku, Tokyo Founded: April 1, 2019 Business: Development of surgical support AI for ischemic stroke and subarachnoid hemorrhage Representatives: Representative Director and CEO, Kenichi Kono Representative Director and COO, Motohisa Kaneko

■Inquiries regarding this release Email: info@imed-tech.co.jp